Literature DB >> 20676150

Successful mobilization of PBSCs in a healthy volunteer donor by addition of plerixafor after failure of mobilization with G-CSF alone.

T Neumann, W H Krüger, C Busemann, T Kiefer, G Dölken.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20676150     DOI: 10.1038/bmt.2010.178

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  5 in total

Review 1.  Plerixafor: a review of its use in stem-cell mobilization in patients with lymphoma or multiple myeloma.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2011-08-20       Impact factor: 9.546

Review 2.  Use of Plerixafor for Stem Cell Mobilization in the Setting of Autologous and Allogeneic Stem Cell Transplantations: An Update.

Authors:  Yavuz M Bilgin
Journal:  J Blood Med       Date:  2021-06-02

3.  Addition of plerixafor in poorly mobilized allogeneic stem cell donors.

Authors:  Lefan Zhuang; Deisen Lauro; Shirong Wang; Shan Yuan
Journal:  J Clin Apher       Date:  2022-05-28       Impact factor: 2.605

4.  Plerixafor as a salvage mobilization strategy for haploidentical peripheral blood allogeneic stem cell transplantation.

Authors:  Michelle Nadeau; Laeth George; Andrew M Yeager; Faiz Anwer; Ali McBride
Journal:  Clin Case Rep       Date:  2015-07-15

5.  Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/CD19-depleted haploidentical stem cell grafts.

Authors:  Sergio Rutella; Perla Filippini; Valentina Bertaina; Giuseppina Li Pira; Lidia Altomare; Stefano Ceccarelli; Letizia P Brescia; Barbarella Lucarelli; Elia Girolami; Gianpiero Conflitti; Maria Giuseppina Cefalo; Alice Bertaina; Tiziana Corsetti; Lorenzo Moretta; Franco Locatelli
Journal:  J Transl Med       Date:  2014-09-02       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.